Study of survival and prognostic factors in patients undergoing resection for gastric linitis plastica: A review of 86 cases

International Surgery

Volumn 84, Issue 4, 1999, Pages 337-343

  Hamy, Antoine ^a   Letessier, Eric ^a   Bizouarn, Philippe ^a   Paineau, Jacques ^a   Aillet, Geneviève ^a   Mirallié, Eric ^a   Visset, Jacques ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Diffuse type gastric cancer; Signet ring cell carcinoma; Stomach cancer

Indexed keywords

ARTICLE; FEMALE; GASTRECTOMY; HUMAN; LINITIS PLASTICA; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH TUMOR; SURVIVAL RATE; TIME;

FEMALE; GASTRECTOMY; HUMANS; LINITIS PLASTICA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 0033202638     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Barwick KW. Linitis plastica: on disease or more? J Clin Gastroenterol 1982; 1: 70-2
2. Oota K, Sobin LH. Types histologiques des tumeurs gastriques et oesophagiennes, No 18. Geneva: WHO, 1977
3. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand 1965; 64: 31-49
4. Ming SC. Gastric carcinoma. A pathological classification. Cancer 1977; 39: 2475-85
5. Japanese Research Society for Gastric Cancer. The general rules for gastric cancer study in surgery and pathology. Jpn J Surg 1981; 11: 127-39
6. Bormann R, Henke F, Lubarsch O. Handbuch der speziellen pathologischen anatomie und histologie, vol 4. Berlin: Springer, 1926; 895
7. Xin Xuan Z, Ueyama T, Enjoji A, Enjoji M. Signet-ring cell carcinoma of the stomach. A quantitative analysis on its submucosal invasion using a computer image analyser. Pathol Res Pract 1992; 188: 1060-6
8. Niitsu Y, Ito N, Kohda K, Owada M, Morita K, Sato S et al. Immunohistochemical identification of type 1 procollagen in tumor cells of scirrhous adenocarcinoma of the stomach. Br J Cancer 1988; 57: 79-82
9. Nagai Y, Sunada H, Sano J, Onodera S, Arai K, Konomi H et al. Biochemical and immunohistochemical studies on the schirrhous carcinoma of human stomach. Ann NY Acad Sci 1985; 460: 321-32
10. Yamamoto R, Tatsuta M, Nakamura H, Matsuzaka T, Terada N, Tamura H. Morphological changes in a human scirrhous gastric carcinoma cell line (KATO III) when cultured in collagen-coated dishes. Virchows Archiv 1988; 55: 247-53
11. Yamashiro K, Suzuki H, Nagayo T. Electron microscopic study of signet-ring cell in diffuse carcinoma of the human stomach. Virchows Archiv 1977; 374: 275-84
12. Kodama Y, Inokuchi K, Okamura T. Tumor cell aggregation and mode of cancer spread in linitis plastica type of gastric carcinoma. GANN 1979; 70: 721-9
13. Shibata T, Ochiai A, Gotoh M, Machinami R, Hirohashi S. Simultaneous expression of cadherin-11 in signet-ring cell carcinoma and stromal cells of diffuse-type gastric cancer. Cancer Lett 1996; 99: 147-53
14. Adam YG, Efron G. Trends and controversies in the management of carcinoma of the stomach. Surg Gynecol Obstet 1989; 169: 371-85
15. Levine M, Kong V, Rubesin S, Laufer I, Herlinger H. Scirrhous carcinoma of the stomach: radiologic and endoscopic diagnosis. Radiology 1990; 175: 151-4
16. Waye JD. Multiple 'spot' biopsy technique of infiltration gastric carcinoma. Mount Sinai J Med 1977; 44: 570-3
17. Faivre J, Moulinier B, Berthezine M, Lesbros F, Lambert R. Les unites plastiques de l'estomac. Etude de 25 cas. Arch Fr Mal App Dig 1976; 65: 277-85
18. Moreaux J, Barrat F, Msika S. La linite plastique de l'estomac. Etude de 102 cas opérés. Résultats du traitement chirurgical. Chirurgie 1986; 112: 485-92
19. Evans E, Harris O, Dickey D, Harhey L. Difficulties in the endoscopic diagnosis of gastric and oesophageal cancer. Aust N Z J Surg 1985; 55: 541-4
20. Balthazar EJ, Siegel SE, Megibow AJ, Scholes J, Gordon R. CT in patients with schirrhous carcinoma of the GI tract: imaging findings and value for tumor detection and staging. AJR 1995; 165: 839-45
21. Akahoshi K, Misawa T, Fujishima T, Chijiiwa Y, Maruoka A, Ohkubo A et al. Preoperative evaluation of gastric cancer by endoscopic ultrasound. Gut 1991; 32: 479-82
22. Bolondi L, Casanova P, Caletti GC, Grigioni W, Zani L, Barbara L. Primary gastric lymphoma versus gastric carcinoma endoscopic US evaluation. Radiology 1987; 165: 821-6
23. Joly JP, Sevestre H, Votte-Lambert A, Capron-Chivrac D, Ducroix P, Dupas JL. Diagnostic de Unite gastrique par échographie percutanée et biopsie échoguidée. Gastroenterol Clin Biol 1994; 18: 289-90
24. Bree RL, McGough MF, Schwab RE. CT or US guided fine needle aspiration biopsy in gastric neoplasm. J Comput Assist Tomograph 1991; 15: 565-9
25. Green J, Katz S, Philips G, Bank S, Hardi C, Hadju E. Percutaneous sonographic needle aspiration biopsy of endoscopically negative gastric carcinoma. Am J Gastroenterol 1988; 83: 1150-3
26. Singh S, MacLeod G, Walker T, McKee G, Bailey ME. Endoscopic fine-needle aspiration cytology in the diagnosis of linitis plastica. Br J Surg 1994; 81: 1010
27. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993; 218: 583-92
28. Walker MJ. A review of carcinoma of the stomach at the tertiary care referral hospital. Am J Surg 1996; 172: 75-8
29. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9
30. Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GNJ. Time trends in gastric carcinoma: changing patterns of type and location. Am J Gastroenterol 1992; 87: 572-9
31. Salvon-Harman JC, Cady B, Nikulasson S, Khettry U, Stone M, Lavin Ph. Shifting proportions of gastric adenocarcinomas. Arch Surg 1994; 129: 381-9
32. Iriyama K, Miki C, Ilunga K, Osawa T, Tsuschibachi T, Suzuki H. Prognostic significance of histological type in gastric carcinoma with invasion confined to the stomach wall. Br J Surg 1993; 80: 890-2
33. Antonioli DA. Current concepts in carcinoma of the stomach. In: Appelman HD (Ed) Pathology of the Esophagus, Stomach, and Duodenum. New York: Churchill Livingstone, 1984; 121-44
34. Nakatsuru S, Yanagisawa A, Ichii S, Tahara A, Kato Y, Nakamura Y et al. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet 1992; 1: 559-63
35. Teh M, Lee YS. HLA-DR antigen expression in intestinal-type and diffuse-type gastric carcinoma. Cancer 1992; 69: 1104-7
36. Segol Ph, Verwaede JC, Fournier JL, Carque M, Marchand P, Arsene D et al. Traitement des cancers de l'estomac. Encycl Med Chir 1987; 9027: A 20-7
37. Dent DM, Werner ID, Novis B, Cheverton P, Brice P. Prospective randomized trial of combined oncological therapy for gastric carcinoma. Cancer 1979; 44: 385-91
38. The Gastrointestinal Tumor Study Group (GITSG). A comparative clinical assessment of combination chemotherapy in the management of advanced gastric carcinoma. Cancer 1982; 49: 1362-6
39. Robertson CS, Chung SCS, Woods SDS, Griffin SM, Raimes SA, Lau JFT et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994; 220: 176-82
40. Jatzko GR, Lisborg PH, Denk H, Klimpfinger M, Settner HM. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside Japan. Cancer 1995; 76: 1302-12
41. Gouzi JL, Huguier M, Fagniez PL, Launois B, Flamant Y, Lacaine F et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg 1989; 209: 162-6
42. Ajani JA, Mansfield PF, Ota DM. Potentially resectable gastric carcinoma: Current approaches to staging and preoperative therapy. World J Surg 1995; 19: 216-20
43. Sendler A, Dittler HJ, Feussner H. Preoperative staging of gastric cancer as precondition for multimodal treatment. World J Surg 1995; 19; 501-8
44. Hermans J, Bonenkamp JJ, Boon MC, Bunt AMG, Ohyama S, Sasako M et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 1993; 11: 1441-7
45. Rougier Ph, Ducreux M, Mahjouby M, Pignon JP, Bellefqih J, Oliveira J et al. Efficacy of combined 5-FU and cisplatinium in advanced gastric carcinomas. A phase II trial with prognostic factor analysis. Eur J Cancer 1994; 30: 1263-9
46. Rougier Ph, Mahjouby M, Lasser Ph, Ducreux M, Oliveira J, Ychou M et al. Neoadjuvant chemotherapy in locally advanced gastric carcinoma-a phase II trial with combined continuous intravenous 5-FU and bolus cisplatinium. Eur J Cancer 1994; 30: 1269-75
47. -Union Internationale Contre le Cancer (UICC). TNM Classification of Malignant Tumors. 4th edn. Geneva: Springer, 1988
48. Haugstvedt TK, Viste A, Eide E, Söreide O and members of the Norwegian Stomach Cancer Trial. Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma. Br J Surg 1993; 80: 475-8
49. Colon KC, Karpeh MS. Laparoscopy and laparoscopic ultrasound in the staging of gastric cancer. Semin Oncol 1996; 23: 347-51
50. Chambon JP, Bosse JL, Denimel F, Porte H, Quandalle P. Place of celioscopy in the diagnosis of invasiveness of digestive cancer. Ann Chir 1995; 49: 513-8
51. Furukawa H, Hiratsuka M, Iwanaga T. A rational technique for surgical operation on Borrmann type 4 gastric carcinoma: left upper abdominal evisceration plus Appleby's method. Br J Surg 1988; 75: 116-9
52. Hautefeuille P, Valleur P, Castaing D. Influence de l'extension ganglionnaire sur la survie après résection des cancers infiltrants. Gastroenterol Clin Biol 1982; 6: 849-56
53. Soga J, Kosayashi J, Saito J, Fujmaki M, Muto T. The role of the lymphadenectomy in curative surgery for gastric cancer. World J Surg 1979; 3: 701-8
54. Boku T, Nakane Y, Okusa T. Strategy for lymphadenectomy of gastric cancer. Surgery 1989; 105: 585-92
55. Miska S, Chastang C, Houry S, Lacaine F, Huguier M. Lymph nodes involvement as the only pronostic factor in curative resected gastric carcinoma: a multivariate analysis. World J Surg 1989; 13: 118-23
56. Oka M, Yoshino S, Hazama S, Shimoda K, Suzuki M, Suzuki T. Prognostic significance of regional lymph node reaction after curative resection of advanced gastric carcinoma. Br J Surg 1992; 79: 1091-4
57. Pacelli F, Bellantone R, Doglieto GB, Alfieri S, Brisinda G, Sgadari A et al. Extensive versus limited lymph nodes dissection for carcinoma of the stomach: a 10-year experience. Br J Surg 1992; Suppl: S49
58. Shiu MH, Moore E, Sanders M, Huvos A, Freedman B, Goodbold J et al. Influence of the extent of resection on survival after curative treatment of gastric carcinoma. Arch Surg 1987; 122: 1347-51
59. Noguchi M, Miyazaki I. Prognostic significance and surgical management of lymph node metastasis in gastric cancer. Br J Surg 1996; 83: 156-61
60. Kaibara N, Sumi K, Yonekawa M, Ohta M, Makino M, Kimura O et al. Does extensive dissection of lymph nodes improve the results of surgical treatment of gastric cancer? Am J Surg 1990; 159: 218-21
61. Dent DM, Madden MV, Price SK. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 1988; 75: 110-2
62. Bonenkamp JJ, Van de Velde CJH. Lymph node dissection in gastric cancer. Br J Surg 1995; 82: 867-9
63. Noguchi Y, Imada T, Matsumoto A, Coit D, Brennan MF. Radical surgery for gastric cancer. A review of the Japanese experience. Cancer 1989; 64: 2053-62
64. Craanen ME, Dekker W, Ferwerda J, Blok P, Tytgat GNJ. Early gastric cancer: a clinicopathologic study. J Clin Gastroenterol 1991; 13: 274-83
65. Moreaux J, Bougaran J. Early gastric cancer. A 25-year surgical experience. Ann Surg 1993; 217: 347-55
66. Murad AM, Santiago FF, Petroianu A, Rocha PRS, Rodrigues MA, Rausch M. Modified therapy with 5-FU, doxorubicin and methotrexate in advanced gastric cancer. Cancer 1993; 72: 37-41
67. Pyrhönen S, Kuitunen T, Nyandoto P, Kouri M. Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FAMTX) plus supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995; 71: 587-91
68. Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ, Mullins RE, Hull WE et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res 1990; 50: 5790-4
69. Fujimoto S, Shresta RD, Kokubun M, Kobayashi K, Kiuchi S, Takahashi M et al. Clinical trial with surgery and intraperitoneal hyperthermic perfusion for peritoneal recurrence of gastrointestinal cancer. Cancer 1989; 64: 154-60
70. Kaibara N, Hamazoe R, Iitsuka Y, Maeta M, Koga S. Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence in gastric cancer. Hepatogastroenterology 1989; 36: 75-8
71. Aranha GV, Georgen R. Gastric linitis plastica is not a surgical disease. Surgery 1989; 106: 785-93
72. Maehara Y, Sakaguchi Y, Moriguchi S, Orita H, Korenaga D, Kohnoe S et al. Signet-ring cell carcinoma of the stomach. Cancer 1992; 69: 1645-50
73. Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Lancet 1994; 343: 112-26